Completed
Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.
NCT04711902
- Conditions
- Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
- Locations
-
- Novartis Investigative Site Chongqing, Chongqing Municipality, China
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Zhuzhou, Hunan, China
- Novartis Investigative Site Baotou, Inner Mongolia, China